Blood transfusions remain critical for saving lives during severe emergencies, surgical procedures, childbirth complications, and the management of critical illnesses. Yet, when donated blood lacks proper screening and compatibility testing, a life-saving intervention can easily trigger fatal medical consequences.
While identifying a donor's blood type serves as an essential initial measure, medical laboratory scientists point out that it falls short of confirming whether the blood is genuinely safe for a recipient. Speaking on clinical standards, specialists Adedoye David and Olaiya Oluwatoba explained that donated blood must undergo additional evaluations, including crossmatching and screening for transfusion-transmissible infections, prior to release.
According to the experts, blood grouping identifies the ABO and Rhesus factors but does not independently establish compatibility between the donor and the recipient. Crossmatching involves testing both blood samples to detect potential adverse interactions between antigens on red blood cells and antibodies present in the recipient's system. Such mismatches can destroy red blood cells, causing severe transfusion reactions.
Furthermore, specialists caution against assuming that O-negative or O-positive blood is universally safe for all recipients. Although group O red blood cells are frequently utilized in emergency scenarios when a patient's exact blood type remains unknown, certain whole-blood donations carry elevated levels of anti-A and anti-B antibodies capable of inducing haemolysis.
What other safety protocols are necessary?
Beyond basic compatibility, preventing the transmission of infectious agents is a cornerstone of safe blood banking. Essential screening protocols cover pathogens such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV 1 and 2), and syphilis. Inadequate screening risks transforming healthcare facilities into pathways for spreading diseases to already vulnerable patients.
Laboratories often rely on enzyme-linked immunosorbent assay (ELISA) as a primary screening tool, though it cannot detect infections during a donor's window period—the phase when an infection exists but remains undetectable by standard tests. Where available, nucleic acid testing (NAT) offers earlier detection by identifying viral genetic material.
What are the risks of unsafe transfusions?
Transfusing incompatible blood frequently results in haemolytic transfusion reactions, wherein the recipient's immune system attacks the introduced red blood cells. Acute reactions manifest rapidly through sudden fevers, chills, low blood pressure, and haemoglobinuria, whereas delayed reactions emerge days or weeks later. Adhering to strict quality controls, as outlined by frameworks like the International Organisation for Standardisation (ISO), helps mitigate these hazards.
While hospitals frequently face blood shortages, experts stress that scarcity must never justify compromising safety standards. Emergency releases prior to full compatibility checks demand strict adherence to protocols, proper documentation, and formal authorization. Laboratory professionals encourage donors and families to inquire about safety procedures, urging open communication to bolster public confidence in transfusion services.